- Home
- ULBI vs COYA Comparison
ULBI vs COYA Comparison
Compare ULBI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- COYA
- Stock Information
- Founded
- ULBI 1990
- COYA 2020
- Country
- ULBI United States
- COYA United States
- Employees
- ULBI N/A
- COYA N/A
- Industry
- ULBI Industrial Machinery/Components
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- ULBI Miscellaneous
- COYA Health Care
- Exchange
- ULBI Nasdaq
- COYA Nasdaq
- Market Cap
- ULBI 128.6M
- COYA 107.0M
- IPO Year
- ULBI 1992
- COYA 2022
- Fundamental
- Price
- ULBI $6.51
- COYA $6.15
- Analyst Decision
- ULBI Strong Buy
- COYA Strong Buy
- Analyst Count
- ULBI 1
- COYA 4
- Target Price
- ULBI $14.00
- COYA $16.50
- AVG Volume (30 Days)
- ULBI 62.9K
- COYA 59.2K
- Earning Date
- ULBI 08-07-2025
- COYA 08-12-2025
- Dividend Yield
- ULBI N/A
- COYA N/A
- EPS Growth
- ULBI N/A
- COYA N/A
- EPS
- ULBI 0.19
- COYA N/A
- Revenue
- ULBI $178,853,000.00
- COYA $423,452.00
- Revenue This Year
- ULBI $31.30
- COYA $40.52
- Revenue Next Year
- ULBI $6.24
- COYA N/A
- P/E Ratio
- ULBI $33.88
- COYA N/A
- Revenue Growth
- ULBI 5.86
- COYA N/A
- 52 Week Low
- ULBI $4.07
- COYA $4.65
- 52 Week High
- ULBI $11.48
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- ULBI 29.47
- COYA 51.12
- Support Level
- ULBI $6.24
- COYA $5.60
- Resistance Level
- ULBI $6.93
- COYA $6.28
- Average True Range (ATR)
- ULBI 0.45
- COYA 0.41
- MACD
- ULBI -0.19
- COYA -0.04
- Stochastic Oscillator
- ULBI 10.31
- COYA 49.11
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.